Censa Pharmaceuticals is a late-stage pharmaceutical company developing CNSA-001 for the treatment of phenylketonuria (PKU) and other diseases associated with defects in the tetrahydrobiopterin biochemical pathways. Censa is Developing Medicines to Improve the Lives of Patients with Debilitating Diseases.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.